相关实验视频
Updated: May 25, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.4K
稳定疾病期间和COPD恶化期间血液中乙氨基酸水平的差异和恶化风险
Wang Chun Kwok1, Terence Chi Chun Tam1, Chi Hung Chau2
1Department of Medicine, The University of Hong Kong, Queen Mary Hospital, 4/F, Professorial Block, 102 Pokfulam Road, Pokfulam, Hong Kong SAR, China.
Lung
|February 27, 2025
概括
稳定状态和COPD急性恶化 (AECOPD) 之间的血中乙氨基酸细胞计数 (BEC) 的差异可以预测未来的事件. 较大的BEC差异表明后续AECOPD的风险更高.
科学领域:
- 肺部病理学 肺部病理学
- 生物标志物 生物标志物
- 呼吸系统医学 呼吸系统医学
背景情况:
- 血中乙氨基酸细胞计数 (BEC) 是慢性阻塞性肺病 (COPD) 的研究生物标志物.
- 在COPD管理中解释单个BEC读数存在挑战.
- 在COPD急性恶化 (AECOPD) 期间BEC变化的预测价值对于未来的事件尚不清楚.
研究的目的:
- 调查基线和AECOPD之间的BEC差异在预测未来AECOPD风险方面的作用.
- 为了确定在恶化期间BEC的变化是否是一个有用的预后标记.
主要方法:
- 前性研究设计.前性研究设计.
- 在COPD患者中分析BEC差异 (绝对乙氨基酸差异:Ei - E0).
- 接收器运行特征 (ROC) 分析以确定BEC差异的截止值.
主要成果:
- 绝对乙酸细胞差异≥105细胞/μL的患者经历了较短的时间到随后的AECOPD (aHR=1.68).
- 这些患者每年发生的AECOPD事件数量也更高 (2.49 vs 1.58事件/年).
- 在基线BEC<300细胞/μL的患者中也观察到类似的趋势.
结论:
- 在基线和中度至重度AECOPD之间,BEC的较大差异与未来恶化的风险增加有关.
- 这种BEC差异可以作为COPD恶化频率和时间的预后指标.
更多相关视频
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K